INTSbenzinga

Intensity Therapeutics, Inc. Announces $2.35M Public Offering At A Combined Purchase Price Per Share And Accompanying Common Warrants Of $0.75

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on April 25, 2025 by benzinga